MannKind (MNKD): RBC Updates Model to Reflect Deal with Sanofi, Lowers PT
Tweet Send to a Friend
RBC Capital maintained an Outperform rating on MannKind (NASDAQ: MNKD) with a modified price target of $13.00 (from $16.00). The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
